Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    -4.00 (-0.18%)
Bid:
2,192.00
Ask:
2,220.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

21 Nov 2014 16:03

RNS Number : 7348X
Genus PLC
21 November 2014
 



21 November 2014

 

 

Genus plc

('Genus' or the 'Company')

 

Director/PDMR Shareholdings

 

Genus announces that conditional nil-cost share options ('Nil-cost Options') were granted yesterday under the Genus plc 2014 Performance Share Plan (the 'PSP') to:

· Karim Bitar, Chief Executive Officer, as to 86,271 ordinary shares of 10 pence each in the Company ('Shares');

· Stephen Wilson, Group Finance Director, as to 51,153 Shares;

· Bill Christianson, Chief Operating Officer, Genus PIC, as to 27,491 Shares;

· Saskia Korink Romani, Chief Operating Officer, Genus ABS, as to 26,690 Shares;

· Jerry Thompson, Chief Operating Officer, Genus Asia, as to 24,563 Shares;

· Jonathan Lightner, Chief R&D and Scientific Officer, as to 26,690 Shares;

· Catherine Glickman, Group Human Resources Director, as to 25,681 Shares; and

· Dan Hartley, Group General Counsel & Company Secretary, as to 37,663 Shares.

Under the PSP, the Nil-cost Options that have been granted are subject to performance conditions that relate to the growth in the Company's adjusted earnings per share over a three-year performance period. Details of the performance conditions that apply to the Nil-cost Options can be found in the Directors' Remuneration Report of the Company's Annual Report & Accounts.

Karim Bitar's direct shareholding in the Company stands at 40,008 Shares representing 0.066% of the issued share capital of the Company that is currently 60,936,794. In addition, he is the beneficial owner of 306,859 Nil-cost Options.

Stephen Wilson's direct shareholding stands at 3,026 Shares representing 0.005% of the issued share capital of the Company. In addition, he is the beneficial owner of 142,058 Nil-cost Options.

Bill Christianson's direct shareholding stands at 29,153 Shares representing 0.048% of the issued share capital of the Company. In addition, he is the beneficial owner of 96,255 Nil-cost Options.

Saskia Korink Romani has no direct shareholding in the Company, is the beneficial owner of 66,561 Nil-cost Options and has contingent rights over 2,076 Shares as part of the terms of her joining.

Jerry Thompson has no direct shareholding in the Company and is the beneficial owner of 17,545 market value Share options under the Genus plc 2004 Executive Share Option Plan and 75,794 Nil-cost Options.

Jonathan Lightner has no direct shareholding in the Company, is the beneficial owner of 53,978 Nil-cost Options and has contingent rights over 8,918 shares as part of the terms of his joining.

Catherine Glickman's direct shareholding in the Company stands at 1,657 Shares representing 0.003% of the issued share capital of the Company. In addition, she is the beneficial owner of 72,130 Nil-cost Options.

Dan Hartley has no direct shareholding in the Company and is the beneficial owner of 37,663 Nil-cost Options. On the same date, in accordance with the terms of joining contained in his employment contract, Dan Hartley was awarded 28,957 Shares, with normal vesting dates of 1 March 2015 as to 14,479 Shares and 1 March 2016 as to 14,478 Shares.

This notification is made in accordance with DR 3.1.4R(1)(a).

For further information please contact:

Cara Crichton

Deputy Company Secretary

Genus plc

Tel: 01256 347100

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUARNRSUAAUAA
Date   Source Headline
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.